Bajaj Auto Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 15, 2025, 1:57 pm

Competitors of Bajaj Auto Ltd

All Competitor Stocks of Bajaj Auto Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:15 pm

Below is a detailed analysis of the quarterly data for Bajaj Auto Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 13,133.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,646.00 Cr. (Mar 2025) to 13,133.00 Cr., marking an increase of 487.00 Cr..
• For Expenses, as of Jun 2025, the value is 10,340.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,289.00 Cr. (Mar 2025) to 10,340.00 Cr., marking an increase of 51.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 2,793.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,358.00 Cr. (Mar 2025) to 2,793.00 Cr., marking an increase of 435.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 19.00% (Mar 2025) to 21.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 509.00 Cr.. The value appears strong and on an upward trend. It has increased from 392.00 Cr. (Mar 2025) to 509.00 Cr., marking an increase of 117.00 Cr..
• For Interest, as of Jun 2025, the value is 224.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 147.00 Cr. (Mar 2025) to 224.00 Cr., marking an increase of 77.00 Cr..
• For Depreciation, as of Jun 2025, the value is 118.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 119.00 Cr. (Mar 2025) to 118.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 2,961.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,484.00 Cr. (Mar 2025) to 2,961.00 Cr., marking an increase of 477.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 25.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 2,210.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,802.00 Cr. (Mar 2025) to 2,210.00 Cr., marking an increase of 408.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 79.15. The value appears strong and on an upward trend. It has increased from 64.52 (Mar 2025) to 79.15, marking an increase of 14.63.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:42 am

Growth

Last Updated: September 5, 2025, 12:15 am

Balance Sheet

Last Updated: November 9, 2025, 1:42 pm

Below is a detailed analysis of the balance sheet data for Bajaj Auto Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 279.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 279.00 Cr..
• For Reserves, as of Sep 2025, the value is 33,891.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34,909.00 Cr. (Mar 2025) to 33,891.00 Cr., marking a decrease of 1,018.00 Cr..
• For Borrowings, as of Sep 2025, the value is 19,693.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9,364.00 Cr. (Mar 2025) to 19,693.00 Cr., marking an increase of 10,329.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 11,593.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,557.00 Cr. (Mar 2025) to 11,593.00 Cr., marking an increase of 2,036.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 65,456.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 54,110.00 Cr. (Mar 2025) to 65,456.00 Cr., marking an increase of 11,346.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 3,661.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,677.00 Cr. (Mar 2025) to 3,661.00 Cr., marking a decrease of 16.00 Cr..
• For CWIP, as of Sep 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Sep 2025, the value is 28,973.00 Cr.. The value appears strong and on an upward trend. It has increased from 28,914.00 Cr. (Mar 2025) to 28,973.00 Cr., marking an increase of 59.00 Cr..
• For Other Assets, as of Sep 2025, the value is 32,764.00 Cr.. The value appears strong and on an upward trend. It has increased from 21,459.00 Cr. (Mar 2025) to 32,764.00 Cr., marking an increase of 11,305.00 Cr..
• For Total Assets, as of Sep 2025, the value is 65,456.00 Cr.. The value appears strong and on an upward trend. It has increased from 54,110.00 Cr. (Mar 2025) to 65,456.00 Cr., marking an increase of 11,346.00 Cr..

Notably, the Reserves (33,891.00 Cr.) exceed the Borrowings (19,693.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Bajaj Auto Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 262.40. This value is within the healthy range. It has decreased from 272.70 (Mar 24) to 262.40, marking a decrease of 10.30.
• For Diluted EPS (Rs.), as of Mar 25, the value is 262.00. This value is within the healthy range. It has decreased from 272.70 (Mar 24) to 262.00, marking a decrease of 10.70.
• For Cash EPS (Rs.), as of Mar 25, the value is 309.91. This value is within the healthy range. It has increased from 279.58 (Mar 24) to 309.91, marking an increase of 30.33.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,260.07. It has increased from 1,037.41 (Mar 24) to 1,260.07, marking an increase of 222.66.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,260.07. It has increased from 1,037.41 (Mar 24) to 1,260.07, marking an increase of 222.66.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,826.06. It has increased from 1,607.22 (Mar 24) to 1,826.06, marking an increase of 218.84.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 427.63. This value is within the healthy range. It has increased from 365.27 (Mar 24) to 427.63, marking an increase of 62.36.
• For PBIT / Share (Rs.), as of Mar 25, the value is 412.80. This value is within the healthy range. It has increased from 352.20 (Mar 24) to 412.80, marking an increase of 60.60.
• For PBT / Share (Rs.), as of Mar 25, the value is 391.31. This value is within the healthy range. It has increased from 350.04 (Mar 24) to 391.31, marking an increase of 41.27.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 295.07. This value is within the healthy range. It has increased from 266.52 (Mar 24) to 295.07, marking an increase of 28.55.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 262.29. This value is within the healthy range. It has decreased from 276.10 (Mar 24) to 262.29, marking a decrease of 13.81.
• For PBDIT Margin (%), as of Mar 25, the value is 23.41. This value is within the healthy range. It has increased from 22.72 (Mar 24) to 23.41, marking an increase of 0.69.
• For PBIT Margin (%), as of Mar 25, the value is 22.60. This value exceeds the healthy maximum of 20. It has increased from 21.91 (Mar 24) to 22.60, marking an increase of 0.69.
• For PBT Margin (%), as of Mar 25, the value is 21.42. This value is within the healthy range. It has decreased from 21.77 (Mar 24) to 21.42, marking a decrease of 0.35.
• For Net Profit Margin (%), as of Mar 25, the value is 16.15. This value exceeds the healthy maximum of 10. It has decreased from 16.58 (Mar 24) to 16.15, marking a decrease of 0.43.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.36. This value is within the healthy range. It has decreased from 17.17 (Mar 24) to 14.36, marking a decrease of 2.81.
• For Return on Networth / Equity (%), as of Mar 25, the value is 20.81. This value is within the healthy range. It has decreased from 26.61 (Mar 24) to 20.81, marking a decrease of 5.80.
• For Return on Capital Employeed (%), as of Mar 25, the value is 27.05. This value is within the healthy range. It has decreased from 32.50 (Mar 24) to 27.05, marking a decrease of 5.45.
• For Return On Assets (%), as of Mar 25, the value is 13.51. This value is within the healthy range. It has decreased from 19.59 (Mar 24) to 13.51, marking a decrease of 6.08.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.17, marking an increase of 0.15.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.26, marking an increase of 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has decreased from 1.20 (Mar 24) to 1.09, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has increased from 1.30 (Mar 24) to 1.68, marking an increase of 0.38.
• For Quick Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.11 (Mar 24) to 1.50, marking an increase of 0.39.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 27.08. This value exceeds the healthy maximum of 8. It has decreased from 27.59 (Mar 24) to 27.08, marking a decrease of 0.51.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 30.49. This value is within the healthy range. It has decreased from 51.39 (Mar 24) to 30.49, marking a decrease of 20.90.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 28.85. This value is within the healthy range. It has decreased from 49.06 (Mar 24) to 28.85, marking a decrease of 20.21.
• For Earning Retention Ratio (%), as of Mar 25, the value is 69.51. This value is within the healthy range. It has increased from 48.61 (Mar 24) to 69.51, marking an increase of 20.90.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 71.15. This value exceeds the healthy maximum of 70. It has increased from 50.94 (Mar 24) to 71.15, marking an increase of 20.21.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 30.71. This value is within the healthy range. It has decreased from 168.95 (Mar 24) to 30.71, marking a decrease of 138.24.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 22.73. This value is within the healthy range. It has decreased from 124.27 (Mar 24) to 22.73, marking a decrease of 101.54.
• For Enterprise Value (Cr.), as of Mar 25, the value is 226,289.42. It has decreased from 256,137.91 (Mar 24) to 226,289.42, marking a decrease of 29,848.49.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.44. This value exceeds the healthy maximum of 3. It has decreased from 5.71 (Mar 24) to 4.44, marking a decrease of 1.27.
• For EV / EBITDA (X), as of Mar 25, the value is 18.95. This value exceeds the healthy maximum of 15. It has decreased from 25.12 (Mar 24) to 18.95, marking a decrease of 6.17.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has decreased from 5.69 (Mar 24) to 4.31, marking a decrease of 1.38.
• For Retention Ratios (%), as of Mar 25, the value is 69.50. This value is within the healthy range. It has increased from 48.60 (Mar 24) to 69.50, marking an increase of 20.90.
• For Price / BV (X), as of Mar 25, the value is 6.25. This value exceeds the healthy maximum of 3. It has decreased from 8.82 (Mar 24) to 6.25, marking a decrease of 2.57.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has decreased from 5.69 (Mar 24) to 4.31, marking a decrease of 1.38.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness